299 related articles for article (PubMed ID: 2547873)
1. Protease-modulation of neutrophil superoxide response.
Kusner DJ; King CH
J Immunol; 1989 Sep; 143(5):1696-702. PubMed ID: 2547873
[TBL] [Abstract][Full Text] [Related]
2. Enhanced release of oxygen metabolites by monocyte-derived macrophages exposed to proteolytic enzymes: activity of neutrophil elastase and cathepsin G.
Speer CP; Pabst MJ; Hedegaard HB; Rest RF; Johnston RB
J Immunol; 1984 Oct; 133(4):2151-6. PubMed ID: 6088632
[TBL] [Abstract][Full Text] [Related]
3. Protease priming of neutrophil superoxide production. Effects on membrane lipid order and lateral mobility.
Kusner DJ; Aucott JN; Franceschi D; Sarasua MM; Spagnuolo PJ; King CH
J Biol Chem; 1991 Sep; 266(25):16465-71. PubMed ID: 1653237
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 augments neutrophil cytotoxic potential via selective enhancement of elastase release.
Johnson JL; Moore EE; Tamura DY; Zallen G; Biffl WL; Silliman CC
J Surg Res; 1998 Apr; 76(1):91-4. PubMed ID: 9695746
[TBL] [Abstract][Full Text] [Related]
5. Inflammation-related neutrophil proteases, cathepsin G and elastase, function as insulin-like growth factor binding protein proteases.
Gibson TL; Cohen P
Growth Horm IGF Res; 1999 Aug; 9(4):241-53. PubMed ID: 10512690
[TBL] [Abstract][Full Text] [Related]
6. Dapsone suppresses human neutrophil superoxide production and elastase release in a calcium-dependent manner.
Suda T; Suzuki Y; Matsui T; Inoue T; Niide O; Yoshimaru T; Suzuki H; Ra C; Ochiai T
Br J Dermatol; 2005 May; 152(5):887-95. PubMed ID: 15888142
[TBL] [Abstract][Full Text] [Related]
7. Progressive inactivation of cathepsin G and elastase released from activated neutrophils in vitro: lack of participation of the neutrophil alpha 1-proteinase inhibitor.
Renesto P; Chignard M
J Lab Clin Med; 1994 Jun; 123(6):906-13. PubMed ID: 8201270
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of neutrophil superoxide production by preincubation with recombinant human tumor necrosis factor.
Berkow RL; Wang D; Larrick JW; Dodson RW; Howard TH
J Immunol; 1987 Dec; 139(11):3783-91. PubMed ID: 2824615
[TBL] [Abstract][Full Text] [Related]
9. CDw17: a neutrophil glycolipid antigen regulated by activation.
Symington FW
J Immunol; 1989 Apr; 142(8):2784-90. PubMed ID: 2703711
[TBL] [Abstract][Full Text] [Related]
10. Beta-adrenergic stimulation down-regulates neutrophil priming for superoxide generation, but not elastase release.
Barnett CC; Moore EE; Partrick DA; Silliman CC
J Surg Res; 1997 Jul; 70(2):166-70. PubMed ID: 9245567
[TBL] [Abstract][Full Text] [Related]
11. Interactions of antirheumatic drugs with the superoxide generation system of activated human polymorphonuclear leukocytes.
Minta JO; Williams MD
J Rheumatol; 1986 Jun; 13(3):498-504. PubMed ID: 3016258
[TBL] [Abstract][Full Text] [Related]
12. Degradation of cartilage matrix proteoglycan by human neutrophils involves both elastase and cathepsin G.
Janusz MJ; Doherty NS
J Immunol; 1991 Jun; 146(11):3922-8. PubMed ID: 2033261
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of recombinant human tumor necrosis factor-alpha by proteolytic enzymes released from stimulated human neutrophils.
van Kessel KP; van Strijp JA; Verhoef J
J Immunol; 1991 Dec; 147(11):3862-8. PubMed ID: 1940372
[TBL] [Abstract][Full Text] [Related]
14. Regulation of neutrophil inflammatory mediator release: chemotactic peptide activation of stimulus-dependent cytotoxicity.
English D; Lukens JN
J Immunol; 1983 Feb; 130(2):850-6. PubMed ID: 6294178
[TBL] [Abstract][Full Text] [Related]
15. Human leukocyte elastase and cathepsin G are specific inhibitors of C5a-dependent neutrophil enzyme release and chemotaxis.
Tralau T; Meyer-Hoffert U; Schröder JM; Wiedow O
Exp Dermatol; 2004 May; 13(5):316-25. PubMed ID: 15140022
[TBL] [Abstract][Full Text] [Related]
16. Effect of E. faecalis on the release of serine proteases elastase and cathepsin G, and collagenase-2 (MMP-8) by human polymorphonuclear leukocytes (PMNs).
Reynaud af Geijersstam A; Sorsa T; Stackelberg S; Tervahartiala T; Haapasalo M
Int Endod J; 2005 Sep; 38(9):667-77. PubMed ID: 16104981
[TBL] [Abstract][Full Text] [Related]
17. Endothelial cell platelet-activating factor primes neutrophil responses: amplification of endothelial activation by neutrophil products.
Vercellotti GM; Moldow CF; Wickham NW; Jacob HS
J Lipid Mediat; 1990; 2 Suppl():S23-30. PubMed ID: 1966817
[TBL] [Abstract][Full Text] [Related]
18. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
Liao CH; Cheng JT; Teng CM
Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil Proteases Activate Eosinophil Function in vitro.
Hiraguchi Y; Nagao M; Hosoki K; Tokuda R; Fujisawa T
Int Arch Allergy Immunol; 2008; 146 Suppl 1():16-21. PubMed ID: 18504401
[TBL] [Abstract][Full Text] [Related]
20. Activation of NADPH oxidase by docosahexaenoic acid hydroperoxide and its inhibition by a novel retinal pigment epithelial protein.
Wu GS; Rao NA
Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):831-9. PubMed ID: 10102279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
